Literature DB >> 23480488

Homovanillic acid in cerebrospinal fluid of 1388 children with neurological disorders.

Marta Molero-Luis1, Mercedes Serrano, Aida Ormazábal, Belén Pérez-Dueñas, Angels García-Cazorla, Roser Pons, Rafael Artuch.   

Abstract

AIM: To determine the prevalence of dopaminergic abnormalities in 1388 children with neurological disorders, and to analyse their clinical, neuroradiological, and electrophysiological characteristics.
METHOD: We studied biogenic amines in 1388 cerebrospinal fluid (CSF) samples from children with neurological disorders (mean age 3y 10mo, SD 4y 5mo; 712 males, 676 females. Correlations among CSF homovanillic acid (HVA) values and other biochemical, clinical, neuroradiological, and electrophysiological parameters were analysed.
RESULTS: Twenty-one patients with primary dopaminergic deficiencies were identified. Of the whole sample, 20% showed altered HVA. We report neurological diseases with abnormal CSF HVA values such as pontocerebellar hypoplasia, perinatal asphyxia, central nervous system infections, mitochondrial disorders, and other genetic diseases. Overlapping HVA levels between primary and secondary dopamine deficiencies were observed. Prevalence of low CSF HVA levels was significantly higher in neonatal patients (χ(2) =84.8, p<0.001). Abnormalities in white matter were associated with low CSF HVA (odds ratio 2.3, 95% confidence interval 1.5-3.5).
INTERPRETATION: HVA abnormalities are observed in various neurological diseases, but some are probably an unspecific finding. No clear limits for CSF HVA values pointing towards primary diseases can be stated. We report several neurological diseases showing HVA alterations. No neuroimaging traits were associated with low HVA values, except for white matter abnormalities. © The Authors. Developmental Medicine & Child Neurology
© 2013 Mac Keith Press.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23480488     DOI: 10.1111/dmcn.12116

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  18 in total

Review 1.  Monoamine neurotransmitter disorders--clinical advances and future perspectives.

Authors:  Joanne Ng; Apostolos Papandreou; Simon J Heales; Manju A Kurian
Journal:  Nat Rev Neurol       Date:  2015-09-22       Impact factor: 42.937

Review 2.  Parkinsonism and inborn errors of metabolism.

Authors:  A Garcia-Cazorla; S T Duarte
Journal:  J Inherit Metab Dis       Date:  2014-06-07       Impact factor: 4.982

3.  Interaction of DRD2TaqI, COMT, and ALDH2 genes associated with bipolar II disorder comorbid with anxiety disorders in Han Chinese in Taiwan.

Authors:  Ming-Chuan Hu; Sheng-Yu Lee; Tzu-Yun Wang; Yun-Hsuan Chang; Shiou-Lan Chen; Shih-Heng Chen; Chun-Hsien Chu; Chen-Lin Wang; I Hui Lee; Po See Chen; Yen Kuang Yang; Ru-Band Lu
Journal:  Metab Brain Dis       Date:  2014-11-29       Impact factor: 3.584

4.  Analysis of human cerebrospinal fluid monoamines and their cofactors by HPLC.

Authors:  Marta Batllori; Marta Molero-Luis; Aida Ormazabal; Mercedes Casado; Cristina Sierra; Angels García-Cazorla; Manju Kurian; Simon Pope; Simon J Heales; Rafael Artuch
Journal:  Nat Protoc       Date:  2017-10-19       Impact factor: 13.491

5.  Cerebrospinal fluid monoamines, pterins, and folate in patients with mitochondrial diseases: systematic review and hospital experience.

Authors:  Marta Batllori; Marta Molero-Luis; Aida Ormazabal; Raquel Montero; Cristina Sierra; Antonia Ribes; Julio Montoya; Eduardo Ruiz-Pesini; Mar O'Callaghan; Leticia Pias; Andrés Nascimento; Francesc Palau; Judith Armstrong; Delia Yubero; Juan D Ortigoza-Escobar; Angels García-Cazorla; Rafael Artuch
Journal:  J Inherit Metab Dis       Date:  2018-07-04       Impact factor: 4.982

Review 6.  Synaptic metabolism: a new approach to inborn errors of neurotransmission.

Authors:  Alba Tristán-Noguero; Àngels García-Cazorla
Journal:  J Inherit Metab Dis       Date:  2018-07-16       Impact factor: 4.982

Review 7.  Movement disorders in patients with Rett syndrome: A systematic review of evidence and associated clinical considerations.

Authors:  Jatinder Singh; Evamaria Lanzarini; Nardo Nardocci; Paramala Santosh
Journal:  Psychiatry Clin Neurosci       Date:  2021-10-21       Impact factor: 12.145

8.  Prevalence of inherited neurotransmitter disorders in patients with movement disorders and epilepsy: a retrospective cohort study.

Authors:  Saadet Mercimek-Mahmutoglu; Sarah Sidky; Keith Hyland; Jaina Patel; Elizabeth J Donner; William Logan; Roberto Mendoza-Londono; Mahendranath Moharir; Julian Raiman; Andreas Schulze; Komudi Siriwardena; Grace Yoon; Lianna Kyriakopoulou
Journal:  Orphanet J Rare Dis       Date:  2015-02-08       Impact factor: 4.123

Review 9.  What is new for monoamine neurotransmitter disorders?

Authors:  Clara Marecos; Joanne Ng; Manju A Kurian
Journal:  J Inherit Metab Dis       Date:  2014-04-03       Impact factor: 4.982

10.  Secondary biogenic amine deficiencies: genetic etiology, therapeutic interventions, and clinical effects.

Authors:  Maja Tarailo-Graovac; Gabriella A Horvath; Clara D van Karnebeek; Ingrid Blydt-Hansen; Allison M Matthews; Vladimir Avramovic; Magda Price; Britt Drogemoller; Casper Shyr; Jessica Lee; Jill Mwenifumbo; Aisha Ghani; Sylvia Stockler; Jan M Friedman; Anna Lehman; Colin J Ross; Wyeth W Wasserman
Journal:  Neurogenetics       Date:  2021-07-02       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.